Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications
Am J Hematol
.
2024 Apr 13.
doi: 10.1002/ajh.27333.
Online ahead of print.
Authors
Tareq Abuasab
1
,
Gautam Borthakur
1
,
Rashmi Kanagal-Shamanna
2
,
Lucia Masarova
1
,
Keyur Patel
2
,
Koichi Takahashi
1
,
Prithviraj Bose
1
,
John Villarreal
1
,
Sherry Pierce
1
,
Tapan Kadia
1
,
Guillermo Garcia-Manero
1
,
Nicholas J Short
1
,
Courtney DiNardo
1
,
Naval Daver
1
,
Farhad Ravandi
1
,
Hagop Kantarjian
1
,
Srdan Verstovsek
1
,
Musa Yilmaz
1
Affiliations
1
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
2
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
PMID:
38613831
DOI:
10.1002/ajh.27333
No abstract available
Publication types
Letter